StonvexLoading…
StonvexStonvexStonvexCore line items from JHG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.10B | $2.47B | $2.10B | $2.20B |
Operating Income | $976.80M | $645.70M | $483.70M | $489.80M |
Net Income | $815.90M | $408.90M | $392.00M | $372.40M |
EPS (Diluted) | $5.23 | $2.56 | $2.37 | $2.23 |
Total Assets | $8.29B | $6.96B | $6.50B | $6.24B |
Total Liabilities | $2.17B | $1.88B | $1.64B | $1.64B |
Cash & Equivalents | $1.25B | $1.22B | $1.15B | $1.16B |
Free Cash Flow OCF − CapEx | $710.90M | $684.50M | $430.80M | $455.70M |
Shares Outstanding | 154.08M | 158.13M | 163.34M | 165.66M |